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Abstract 
The contribution of glial cells to the pathophysiology of depression is an emerging 
research purpose. This study investigated the deficits in glial cells, specifically astrocytes 
in various brain regions, after the development of depression and then after voluntary 
running in depressed rats. Forty-five adult male Wistar rats aged 8-10 weeks were used in 
the study. A depression model was generated through a forced swimming Programe; 
voluntary running was allowed on rat running wheels; and brain sections were taken from 
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the hippocampus, dentate gyrus (DG), medial prefrontal cortex (mPFC) and cerebellar 
cortex. After immunostaining with specific antibodies immuno-stain, the astrocytes, 
oligodendroglia and microglial cells were counted, and certain indices relating astrocytes 
to other glial cells were calculated. Astrocytic morphology was studied, and the optical 
density (OD) of glial fibrillary protein (GFAP) immuno-expression was measured in 
different groups. Compared to the control group, animals in the depression group exhibited 
significant decreases in the mean astrocyte count in all studied brain areas, significant 
decreases in GFAP OD values in all areas and significantly reduced values for all glial 
astrocyte indices in the hippocampus, DG and mPFC. Compared to the rats in the 
depression group, those in the depression/exercise group exhibited significantly elevated 
mean astrocyte and oligodendroglia counts in all studied areas, significantly elevated 
GFAP OD values in all studied areas, and non-significant differences in glial astrocyte 
indices in the hippocampus, mPFC and cerebellar cortex. Astrocytes, rather than other glia, 
constitute a basis for the development and/or relief of depression. 
Key words: stress, dentate gyrus, hippocampus, cerebellum, frontal cortex, glial cells, 
voluntary running 
 
 
INTRODUCTION 
Depression is a neuropsychiatric ailment that has a major impact on socio-
economic status. This disorder results from maladaptive neuroplastic processes in the 
cellular structures concerned with emotional processing, such as the prefrontal cortex 
(PFC), hippocampus and amygdala [1]. Neurotrophins and neuroplasticity are generally 
accepted to play an essential role in the pathophysiology of depression. However, the 
disturbance of synaptic plasticity due to glial cell pathology, particularly in the 
frontolimbic areas of the brain, is an emerging proposed mechanism that may substantially 
contribute to the pathophysiology of mood disorders [2]. 
Physical exercise can provide relief for depressed mood, but the underlying 
mechanisms remain uncertain. Studies designed to identify these mechanisms have 
discussed the changes in neurons with slight attention paid to changes in glial cells [3].  
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The term neuroglia describes all supporting non-neuronal cells in the central 
nervous system (CNS) that represent the homeostatic and defensive arm of nervous 
system[4]. Recently, a system of complex crosstalk between neurons and glia has been 
proposed, and the active role for glial cells in central homeostatic processes has been 
presented [5]. 
Astrocytes are a heterogeneous class of glial cells that preserve the neural 
microenvironment [6]. Their dynamic role in shaping synaptic function and their impact on 
behavioural expression are noteworthy [2]. Microglia are specific immune cells of the CNS 
that are highly dynamic, surveying the brain parenchyma and contributing to 
neuroprotection. During neurogenesis, microglia have a role in determining the ultimate 
patterns of the neural circuits important for behaviour and disease development [7]. These 
glia also have a critical role in the synaptic carving needed for adaptive brain function [8]. 
Oligodendroglia are myelin-forming cells that are generated continuously in healthy adult 
brains for regulation of the axonal function[9]. 
Experimental studies on the pathophysiology of depression usually focus on 
neuronal changes, with little attention has paid to changes in the neuroglia. This study 
aimed to consider changes in astrocytic counts and morphology in the hippocampus, 
dentate gyrus (DG), medial prefrontal cortex (mPFC) and cerebellar cortex of Wistar rats 
in an experimental depressive state and after voluntary running. 
 
MATERIALS AND METHODS 
This experimental study was conducted in the behaviour laboratory of the College 
of Medicine, Taibah University, Saudi Arabia. Cell counting and analysis were performed 
in the Department of Histology at the Bogomolets National Medical University, Ukraine. 
The animal handling was conducted in accordance with EC Directive 86/609/EEC for 
animal studies and the National Committee guidelines of Saudi Arabia. 
 
Experimental animals 
Fifty-five adult male Wistar rats aged 8-10 weeks and weighing 200-250 g were 
obtained from the animal house of the behaviour laboratory, housed in the laboratory for 7 
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days for acclimatization, and observed for their movements and food consumption as 
markers of their ordinary behaviour. A 6-minute forced swimming test (FST) was 
performed for choosing rats with extreme test behaviour (less immobility duration and 
high distance moved)[10]. Selected animals (n=45 rats) were housed in ventilated cages (5 
animals/cage) with a standard chow diet and an adjusted laboratory environment (12/12-
hour light/dark cycle, 22-24°C, 50-60% humidity) [3,11]. 
Selected rats were randomly divided into 3 equal groups as follows: 
 Control group: Rats were fed a standard chow diet for a period of 5 weeks  
 Depression group: Rats were subjected to the forced swimming Programe for two weeks 
and then fed the standard chow diet for the following 3 weeks  
 Depression/exercise group: Rats were subjected to the forced swimming Programe for 
two weeks and then allowed to voluntary wheel running for the following 3 weeks.  
For all groups, the locomotor activities of the rats were assessed by the 6-minute FST 
before being sacrificed. 
 
Induction of depression 
Depression was induced by forced swimming inside an upright glass cylinder 
inclosing water (water height 45 cm and temperature at 23-25°C) for 15 min daily for 14 
days. Every day after swimming, the rats were allowed to dry (32°C) for 15 min before 
being returned to their cages [3]. 
 
Accessing voluntary running 
the rats were allowed to run voluntarily for 3 weeks in rat running wheels supplied with 
counters (Lafayette Instrument Company, Inc. Lafayette, IN, USA).  
 
Confirmation of the development and/or the relief of the depressive state 
Two means were used to confirm the development or relief of a depressive state just 
before the rats were euthanized: 
 The 6-minute FST, through automatic tracing via a software (Ethovision XT version 
8.0, Noldus Information Technology, Wageningen, The Netherlands), was conducted to 
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assess the locomotor behaviour of the rats in terms of a) immobility duration (in 
seconds) and b) the distance the rats moved (in centimetres) [12]. 
 Quantification of serum corticosterone levels; in the morning, after anaesthetising the 
rats with ether, blood was collected from the retro-orbital veins and put into serum 
separation tubes for centrifugation. The sera were reserved in −80°C until the levels of 
corticosterone (ALPCO Diagnostics, Orangeburg, NY, USA) were measured using 
ELISA kits rendering the manufacturers’ instructions [13,14]. 
 
Tissue preparation and quantification of glial cells 
At the quantified time, the rats were sacrificed by cervical dislocation and perfused 
with  formaldehyde (4%) in phosphate-buffered saline. The brains were removed, 
coronally sectioned, and fixed in buffered formalin for histological examination of the 
hippocampus, DG, mPFC and cerebellar cortex. Brain tissue thin sections (4-5 µm) were 
immunostained with polyclonal anti-rat antibodies (Dako Cytomation, USA) against a. 
glial fibrillary acidic protein (GFAP); b. myelin basic protein (MBP); and c. cluster of 
differentiation 68 (CD68). The staining procedure was performed as previously described 
[15] with an immunoperoxidase technique and a Bench-Mark instrument (Ventana 
Company, Oro Valley, Arizona, USA) briefly; The paraffin sections were deparaffinised, 
rehydrated, treated with 3% H2O2 for 5 min and washed with phosphate-buffered saline 
(PBS) for 15 min. The sections were blocked with 1.5% normal goat serum in PBS to 
control background staining and then incubated for 45 min at room temperature with the 
primary antibody. The sections were subsequently incubated with a second-stage 
biotinylated antibody at room temperature. After rinsing with PBS, the reaction products 
were visualised by immersing the sections in diamnobenzidine. Finally, the sections were 
counter- stained with haematoxylin, dehydrated and cover-slipped using Protex mounting 
media (DAB- Stock Stain box; Boster Biotechnology, Pleasanton, CA, USA)[16]. 
Sections were examined with a bright field automated microscope (Olympus BX 36 
provided with a true-colour image analysis software package), photographs were captured 
from different brain sections to represent all strata of the hippocampus (alveus, oriens and 
radiatum and pyramidal), all layers of the DG (molecular, granular and polymorphic), all 
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cell layers of the cerebellar cortex (molecular, Purkinje and granular) and all layers of the 
mPFC (molecular, outer granular, pyramidal, inner granular layer, ganglionic and 
multiform). The images were digitized by a DP27 digital video camera (2448×1920-pixel 
matrix) to identify different types of glial cells; GFAP+ve astroglia, MBP+ve 
oligodendroglia, and CD68+ve microglia[15] (Fig. 1). Cell counting was performed in the 
Department of Histology at the Bogomolets National Medical University, Ukraine. For 
each group, the stained astrocytes, oligodendroglia and microglia were counted at 400X in 
15 fields from the selected sections of the four brain regions. 
 
The glial astrocyte indices 
Three glial astrocyte indices (GAI) were calculated as a simple way to express the 
ratio of astrocytic count to the counts of other types of glia and to explore the impact of 
altered astrocytic numbers on glial structural homeostasis in the context of depression and 
also after voluntary running of depressed rats. They were expressed as follows: a) GAI1 
(А/М) = number of astrocytes/the number microglia; b) GAI2= number of astrocytes/ 
number of oligodendroglia; and c) GAI3 (А/T) = number of astrocytes/total number of 
counted glial cells. 
 
The measurement of optical densities (ODs) of the GFAP 
The optical densities (ODs) of the GFAP-stained sections were measured as 
described by Varghese et al[17] in five illustrative non-overlapping fields (×400). The 
images were deconvoluted via the DAB vector, the brown DAB images were calibrated 
and the mean grey value. The OD was calculated using the equation: [OD=log (max 
intensity/mean intensity)], where max intensity=250 and mean intensity=mean grey value. 
 
Statistical analysis 
Statistical analyses were done with the IBM SPSS statistical package (version 21). 
The data were stated as the mean ± standard error (SE). The means of the studied groups 
were compared using one-way ANOVA with the least significant different (LSD) test for 
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analysis of the locomotor parameters, corticosterone levels, glial cell counts and glial 
astrocyte indices. Statistical significance was set at P<0.05. 
 
RESULTS 
The development and relief of the depressive state 
The mean immobility duration recorded for the depression group was significantly 
higher than that for the control group. Further, the mean immobility duration recorded for 
the depression/exercise group was significantly lower than that for the depression group 
(Fig. 2). 
The mean distance moved by the rats in the depression group was significantly 
lower than that moved by the rats in the control group. Also, the mean distance moved by 
the rats in the depression/exercise group was significantly higher than that recorded for the 
depression group (Fig. 2). 
The mean serum corticosterone level was significantly higher in the depression 
group than in the control group. Furthermore, it was significantly lower in the 
depression/exercise group than in the depression group (Fig. 3). 
 
Glial cell counts and glial astrocyte indices 
The mean numbers and significance of the glial cells and glial astrocyte indices are 
presented in table1 and table 2. Changes in the mean numbers of astrocytes in different 
regions for all groups are shown in Fig. 4. 
The mean number of astrocytes was significantly lower in the depression group 
than in the control group in all studied brain areas (hippocampus, DG, mPFC and 
cerebellar cortex). However, no significant differences were detected for either 
oligodendroglia or microglia in the hippocampus, DG and mPFC between the depression 
group and the control group. Only oligodendroglia was significantly decreased in number 
in the cerebellar cortex. 
Total glial cell counts were significantly lower in the depression group than in the 
control group in all studied brain areas except in the mPFC, where the decrease was not 
significant. 
8 
 
Excitingly, all glial astrocyte indices (GAI1, GAI2 and GAI3) were significantly 
lower in the depression groups than in the control group in all studied brain areas, except 
for a non-significant decrease in GAI1 and GAI3 in the cerebellar cortex. 
The mean numbers of astrocytes and oligodendroglia were significantly higher in 
the depression/exercise group than in the depression group in all studied brain areas 
(hippocampus, DG, mPFC and cerebellar cortex). The mean number of microglia was 
different in different regions (increased significantly in the DG and mPFC, decreased 
significantly in the hippocampus, and no significant increase in the cerebellar cortex). 
Total glial cell counts were significantly higher in the depression/exercise group 
than in the depression group in all studied brain areas except in the hippocampus, where 
the increase was not significant. 
Notably, no significant differences were found in any of the glial astrocyte indices 
in the hippocampus, mPFC or cerebellar cortex. In the DG, significant decreases in GAI1 
and GAI3 were detected, but these decreases were accompanied by highly significant 
increases in the numbers of microglia and oligodendroglia. 
 
GFAP immunohistochemical study 
An examination of the hippocampus, DG, mPFC and cerebellar cortex in the 
control group revealed star-shaped astrocytes with dense, distinct, dark cell bodies and 
complex and “bushy”, densely packed processes (Fig. 5; A1, 2, 3, 4). In depressed rats, 
astrocytes were dispersed in all examined brain regions and displayed relatively indistinct 
cell bodies and distorted processes (Fig. 5; B1, 2, 3, 4). In the depression/exercise group, 
astrocytes in all regions appeared to regain their immune reactivity, exhibiting denser cell 
bodies and complex, denser process extensions than the depression group (Fig. 5; C1, 2, 3, 
4). 
Compared to the control group, depression caused a significant decrease in GFAP 
OD in the hippocampus (P=0.013), DG (P<0.001), mPFC (P<0.001), and cerebellar cortex 
(P<0.001) (Fig. 6).  
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Compared to the depression group, running caused a significant increase in GFAP 
OD in the hippocampus (P=0.042), DG (P=0.027), mPFC (P=0.037), and cerebellar cortex 
(P=0.026) (Fig. 6). 
 
DISCUSSION 
The development of depression and/or its relief were assessed both mechanically 
by evaluating locomotor behaviours (through FST) or biochemically by evaluating the 
serum corticosterone levels in all groups. The significant decrease of the distance moved, 
the significant increase in the immobility duration and the increased corticosterone levels 
after the forced swimming protocol confirmed the development of depression. Similarly, a 
significant increase in the mean distance moved, a significant decrease in the mean 
immobility duration and a significant decrease in serum cortisone levels occurred after a 
voluntary running protocol confirmed the relief of depressive behaviour [13,18]. 
Depression was primarily proposed to develop due to increased levels of 
corticosteroids [19]; later, neurotrophic factors and disordered neuroplastic processes in the 
frontal cortex and limbic system were proposed as underlying mechanisms [3,20]. Based 
upon the emerging concept that glial cells, specifically astrocytes, are critical factors 
affecting brain plasticity [2], this study evaluated the changes in glial cells (specifically 
astrocytes) in the hippocampus, DG, mPFC, and cerebellar cortex as a key mechanism 
triggering the pathophysiology of depression. 
The significant decrease in the mean total glial cell counts in the hippocampus, DG, 
and cerebellar cortex reflected the contribution of glial cells to the pathophysiology of 
depression. This finding was consistent with a recorded reduction in glia during depression 
that was proven to precede the decreased neuronal density, which appears to occur later 
after longer periods of depression [21]. 
The significant decrease in the mean number of astrocytes, along with non-
significant differences in the mean count of oligodendroglia or microglia, in most of the 
examined brain areas, can reflect the major role of astrocytes in the pathology of 
depression. Additionally, the decreased glial astrocyte indices can outline the role of 
astrocytes over other glia in the development of depression. These findings are in 
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consistent with the reported decreased density of astrocytes associated with synaptic 
dysfunction in the frontolimbic regions during depression [2] and in the hippocampus 
during chronic stress [22]. 
It is imperative to consider that the contribution of glial cells to the pathogenesis of 
depression is not contradicted by the old theories of depression that attributed the 
development of depression to the raised corticosterone or deficits in neurotrophic factors 
[1,20] as these factors have an impact on glial function [2], however, the role of astrocytes 
and glial-glial interactions in controlling depressive behaviour constitutes a new era of 
neuroscience research. These cells play major roles in synaptic function in specified brain 
regions [23,24], and have tough  interactions with the synapses that make it difficult to 
distinguish whether the dysfunction resulted from neuronal or astrocyte modifications [25] 
In accordance with our results, some evidence supports the idea that astrocyte 
modification in some brain areas leads to depression [26]. In humans, post-mortem brain 
samples from adults suffering from major depressive disorder showed a decreased number 
of astrocytes in the frontolimbic structures [27]. 
The significant decrease in the OD of GFAP immune-expression in the brain areas 
in the depression group was consistent with other studies that described a modification in 
the density of different astrocytic markers in the frontolimbic regions in major depressive 
disorder [28]. Moreover, GFAP-expressing cells are decreased in the PFC after 5 weeks of 
chronic stress [22] and in genetically stressed Wistar Kyoto rats [29]. Furthermore, 
postmortem brain samples showed decreased GFAP expression in the hippocampus and 
PFC, with no neuronal effects, although defective neuronal metabolism or connections 
have been suggested [30]. 
Regarding the cerebellum, the significant reduction in the number of astrocytes and 
in the OD of GFAP in the cerebellar cortex of rats in the depression group could represent 
an indication for the involvement of the cerebellar cortex in the pathophysiology of 
depression, as previously suggested [31]. One possible explanation is the known 
anatomical and functional connections of the cerebellum to the PFC and the subcortical 
limbic structures [32]. Nonetheless, in the cerebellum, oligodendroglia are involved in 
cerebellar pathology, with a significant decrease in their mean count in the depression 
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group, which could explain the non-significant decreases in GAI1 and GAI3 that were 
specifically observed in the cerebellar cortex. 
Practising voluntary running by depressed rats improved the depressive locomotor 
behaviour and produced a significant increase in the total glial cell counts and significant 
increase of the OD of the GFAP-stained sections in the brain areas. This can indicate the 
concomitant improving effect on glial cell counts with the improvement of the depressive 
behaviour after voluntary running. This was consistent with the observed alleviation of 
depression-like symptoms and the enhancement of synaptic, and glial measures in several 
brain regions upon exercise [4].  
The increased number of astrocytes in the mPFC, hippocampus and DG, along with 
improved depressive behaviour after voluntary running, are in line with the suggested 
physical activity-induced plasticity of astrocytes and inhanced synaptic markers in the 
brain regions for cognition [33]. The improved behaviour might be due to the trophic 
support and regulation of neuronal blood flow by astrocytes, which influence neuronal 
function and synaptic growth[31,34]. 
Also, the improved astrocytic counts and increased GFAP expression after running 
are consistent with the suggested important glioprotective effects and the prevention of 
stress-induced decreases in GFAP expression in the hippocampus after treatment with 
antidepressants [35].  
Notably, although astrocyte counts increased in all brain areas after running, there 
were non-significant increases in the proposed glial astrocyte indices in the hippocampus, 
mPFC and cerebellar cortex. This finding showed that voluntary running increased the 
astrocyte count to levels capable of preserving neurons and oligodendroglia, limiting brain 
tissue degeneration and preserving the function without reaching the levels of astrogliosis, 
which can lead to neurotoxicity, potential neural dysfunction and the development of 
neurodegeneration [36]. The significant decreases in GAI1 and GAI3 in the DG can be 
explained by the specifically significant increase in microglia to this region, which might 
be enhanced to help shaping the final patterns of neural connections during neurogenesis 
[7,37]. 
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CONCLUSIONS 
These collected data provide evidence for a prominent role of glial cells in the 
pathology of depression. Furthermore, the study presents significant changes in astrocyte 
count and/or morphology in the hippocampus, DG, mPFC and cerebellar cortex in 
depression. The study reveals the noteworthy ability of voluntary running to reverse the 
effects of depression on the abundance of astrocytes and on their specific marker GFAP in 
the brain regions associated with depression. Additionally, this work provides evidence 
that both astrocytes and oligodendroglia are implicated in the mitigating effect of voluntary 
running on depression in the hippocampus, DG, mPFC and cerebellar cortex. 
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Fig. 1: Photographs of sections of the control medial frontal cortex stained for a) glial fibrillary 
acidic protein (GFAP) to detect astrocytes; b) myelin basic protein (MBP) to detect 
oligodendroglia; c) cluster of differentiation 68 (CD68) to detect microglia (GFAP, MBP 
and CD68, 400× magnification). 
 
 
Fig. 2: Graphs showing the results from behaviour tracings during the 6-minute FST for all 
groups: (a) immobility duration and (b) distance moved. 
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Fig. 3: Graph showing the changes in mean serum corticosterone levels in different groups. 
 
 
 
Fig. 4: Graph showing the changes in mean astrocytic counts in different brain areas. 
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Fig. 5: Plate showing immunohistochemistry for GFAP-positive cells (arrows) in the brain 
areas of different groups. In the control group (a), astrocytes display dense, distinct, dark 
cell bodies and “bushy”, densely packed processes in the hippocampus (a1), DG (a2), 
mPFC (a3) and cerebellar cortex (a4). In the depression group (b), the astrocytes appear 
dispersed and display relatively indistinct cell bodies and distorted processes in the 
hippocampus (b1), DG (b2), mPFC (b3) and cerebellar cortex (b4). In the 
depression/exercise group (c), the astrocytes appeared to regain their immunoreactivity, 
exhibiting dense cell bodies and complex, dense process extensions in the hippocampus 
(c1), DG (c2), mPFC (c3) and cerebellar cortex (c4) (GFAP, 1000× magnification). 
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Fig. 6: Graph showing the mean OD values of GFAP immunostaining in different brain areas of 
different groups.  
 
Table 1. Means and significance of different glia cells’ numbers and the total glia cells’ 
counts in different groups in all examined brain areas. 
Regions Variables 
Control 
(n=15) 
Depression 
(n=15) 
Depression/Exercise 
(n=15) P value 
Dentate 
gyrus 
Astrocytes 38.8±5.6 11.8±3.1 
 
22.07±1 
P1<0.001* 
P2=0.004* 
Oligodendroglia 11.47±2.1 9.2±0.8 
 
98±10.5 
P1=0.314 
P2<0.001* 
Microgliocytes 4.9±0.3 5.7±0.7 
 
16±1.9 
P1=0.255 
P2<0.001* 
Total glia cells 55.1±6.3 26.7±3.2 
 
136.1±10.1 
P1=0.007* 
P2<0.001* 
Medial 
frontal cortex 
Astrocytes 21±4 9.2±3 
 
16.5±1.1 
P1=0.027* 
P2=0.033* 
Oligodendroglia 7.7±1.2 11.1±1.7 
 
30.5±5.6 
P1=0.11 
P2=0.003* 
Microgliocytes 11.3±1.5 8.9±0.8 
13.9±1.3 P1=0.196 
P2=0.004* 
Total glia cells 39.9±4.5 29.2±3.7 
60.8±5.1 P1=0.098 
P2<0.001* 
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Hippocampus 
Astrocytes 30.6±2.6 15.7±2.8 
22.8±0.8 P1<0.001* 
P2=0.024* 
Oligodendroglia 21.7±2.6 18.5±2.2 
26.7±0.8 P1=0.368 
P2=0.002* 
Microgliocytes 10.9±1.6 10.7±1 
7.7±0.7 P1=0.918 
P2=0.018* 
Total glia cells 63.2±3.8 45±4.1 
57.3±1.6 P1<0.001* 
P2=0.871 
Cerebellar 
cortex 
Astrocytes 8±1.2 4.33±0.4 
5.8±0.3 P1=0.007* 
P2=0.01* 
Oligodendroglia 238.3±14 180±10.3 
353.3±15.2 P1=0.002* 
P2<0.001* 
Microgliocytes 4.2±0.4 4.3±0.3 
4.7±0.3 P1=0.777 
P2=0.301 
Total glia cells 250.5±14 188±10.4 
363.8±15.2 P1=0.002* 
P2<0.001* 
P1 significance of the depression group compared to the control group. Significance at p< 0.05  
P2 significance of the depression/exercise group compared to the depression group. Significance at p< 0.05 
 
 
Table 2. Astrocytic indices and significance in different groups in all examined brain 
areas. 
Regions 
Glial 
Glial 
Astrocyte 
Indices 
Control 
(n=15) 
Depression 
(n=15) 
Depression/Exercise 
(n=15) 
P value 
Dentate 
gyrus 
GAI1 
(А/М) 
4.1±0.5 1.6±0.5 0.3±0.1 
P1=<0.001* 
P2=0.029* 
GAI2 
(A/O) 
8.4±1.3 2.3±0.7 1.6±0.1 
P1<0.001* 
P2=0.534 
GAI3 
(А/Total) 
0.7±0.04 0.4±0.1 0.2±0.03 
P1<0.001* 
P2=0.022* 
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Medial 
frontal cortex 
GAI1 
(А/М) 
3.8±0.8 1±0.3 0.8±0.1 
P1<0.001* 
P2=0.805 
GAI2 
(A/O) 
2.7±0.8 1±0.4 1.4±0.2 
P1=0.023* 
P2=0.640 
GAI3 
(А/Total) 
0.5±0.1 0.2±0.1 0.3±0.02 
P1<0.001* 
P2=0.269 
Hippocampus 
GAI1 
(А/М) 
2.6±0.8 0.9±0.2 0.7±0.1 
P1=0.015* 
P2=0.872 
GAI2 
(A/O) 
7.5±1.6 2.7±0.5 2.5±0.2 
P1=0.001* 
P2=0.899 
GAI3 
(А/Total) 
0.5±0.3 0.3±0.05 0.4±0.01 
P1<0.001* 
P2=0.052 
Cerebellar 
cortex 
GAI1 
(А/М) 
0.04±0.007 0.03±0.003 0.02±0.002 
P1=0.072 
P2=0.165 
GAI2 
(A/O) 
1.9±0.3 1.02±0.1 1.3±0.1 
P1<0.001* 
P2=0.291 
GAI3 
(А/Total) 
0.03±0.006 0.02±0.003 0.02±0.002 
P1=0.061 
P2=0.192 
GAI1 (А/М) = number of astrocytes/ number of microglia; GAI2 (A/O) = number of astrocytes/ number of 
oligodendroglia; and GAI3 (А/T) = number of astrocytes/total number of counted glial cells.  P1 significance 
of the depression group compared to the control group. P2 significance of the depression/exercise group 
compared to the depression group. Significance at p< 0.05 
